source
- FDA issues early alert on Resmed Astral ventilators due to electrical component failure riskThe FDA’s Center for Devices and Radiological Health has released an early alert warning about a possible high-risk problem with certain Resmed Astral ventilators. A defective electrical component…
- Attovia Therapeutics and Braveheart Bio announce plans for biotech IPOs amid market upswingAttovia Therapeutics and Braveheart Bio disclosed on Tuesday that they intend to go public, joining a recent wave of large biotech offerings. Attovia, which was spun out of Alamar Biosciences in 2…